Sfoglia per Autore
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity.
2005 Spadaro M; Ambrosino E; Iezzi M; Di Carlo E; Sacchetti P; Curcio C; Amici A; Wei WZ; Musiani P; Lollini PL; Cavallo F; Forni G.
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
2005 Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musiani P; Cavallo F; Forni G; Nanni P; Lollini PL.
New target antigens for cancer immunoprevention
2005 Lollini PL; Nicoletti G; Landuzzi L; De Giovanni C; Nanni P.
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.
2005 Astolfi A; Rolla S; Nanni P; Quaglino E; De Giovanni C; Iezzi M; Musiani P; Forni G; Lollini PL; Cavallo F; Calogero RA.
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention
2005 F. Cavallo; A. Astolfi; M. Iezzi; F. Cordero; P.-L. Lollini; G. Forni; R. Calogero
Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice.
2005 Cuadros C; Dominguez AL; Lollini PL; Croft M; Mittler RS; Borgstrom P; Lustgarten J.
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice.
2005 Lo Iacono M; Cavallo F; Quaglino E; Rolla S; Iezzi M; Pupa SM; De Giovanni C; Lollini PL; Musiani P; Forni G; Calogero RA.
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant negative p53 makes their growth independent of HER-2/neu expression.
2006 T. Pannellini; M. Spadaro; E. Di Carlo; E. Ambrosino; M. Iezzi; A. Amici; P.-L. Lollini; G. Forni; F. Cavallo; P. Musiani
Genetic algorithm against cancer.
2006 F. Pappalardo; E. Mastriani; P.-L. Lollini; S. Motta
Analysis of vaccine’s schedules using models. Nota bene: e' un lavoro del 2007, come attestato dai dati stampati nel lavoro stesso (Received 5 February 2007; accepted 11 February 2007; Available online 17 April 2007), ma il fascicolo della rivista, per qualche motivo di carattere editoriale, e' datato December 2006.
2006 F. Pappalardo; S. Motta; P.L. Lollini; E. Mastriani
Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role.
2006 A. Palladini; A. Astolfi; S. Croci; C. De Giovanni; G. Nicoletti; A. Rosolen; F. Sartori; P.-L. Lollini; L. Landuzzi; P. Nanni
Terapia molecolare dei sarcomi
2006 P.L. Lollini
Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma
2006 K. Scotlandi; S. Perdichizzi; G. Bernard; G. Nicoletti; P. Nanni; P.-L. Lollini; A. Curti; M. C. Manara; S. Benini; A. Bernard; P. Picci
Vaccines for tumour prevention
2006 Lollini P.L.; Cavallo F.; Nanni P.; Forni G.
Cancer biology, what we know and what we don't know.
2006 P. Nanni; C. De Giovanni; P.-L. Lollini
Modeling tumor immunology.
2006 P.-L. Lollini; S. Motta; F. Pappalardo.
CD99 Acts as an Oncosuppressor in Osteosarcoma.
2006 Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.; Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K.
Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator.
2006 P.-L. Lollini; S. Motta; F. Pappalardo
Model deconstruction of an immunoprevention vaccine
2006 F. Pappalardo; P.-L. Lollini; S. Motta; E. Mastriani.
Development of a K-edge micro CT for the study of tumor angiogenesis in small animals
2006 G. Baldazzi; D. Bollini; M. Gambaccini; R. Golfieri; P. L. Lollini; A. Margotti; S. Masetti; G. Nicoletti; G. Pancaldi; L. Roma; P.L. Rossi; M. Zuffa
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. | Spadaro M; Ambrosino E; Iezzi M; Di Carlo E; Sacchetti P; Curcio C; Amici A; Wei WZ; Musiani P; L...ollini PL; Cavallo F; Forni G. | 2005-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. | Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musi...ani P; Cavallo F; Forni G; Nanni P; Lollini PL. | 2005-01-01 | THE AMERICAN JOURNAL OF PATHOLOGY | - | 1.01 Articolo in rivista | - |
| New target antigens for cancer immunoprevention | Lollini PL; Nicoletti G; Landuzzi L; De Giovanni C; Nanni P. | 2005-01-01 | CURRENT CANCER DRUG TARGETS | - | 1.01 Articolo in rivista | - |
| Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario. | Astolfi A; Rolla S; Nanni P; Quaglino E; De Giovanni C; Iezzi M; Musiani P; Forni G; Lollini PL; ...Cavallo F; Calogero RA. | 2005-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention | F. Cavallo; A. Astolfi; M. Iezzi; F. Cordero; P.-L. Lollini; G. Forni; R. Calogero | 2005-01-01 | BMC BIOINFORMATICS | - | 1.01 Articolo in rivista | an integrated.pdf |
| Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice. | Cuadros C; Dominguez AL; Lollini PL; Croft M; Mittler RS; Borgstrom P; Lustgarten J. | 2005-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. | Lo Iacono M; Cavallo F; Quaglino E; Rolla S; Iezzi M; Pupa SM; De Giovanni C; Lollini PL; Musiani... P; Forni G; Calogero RA. | 2005-01-01 | INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant negative p53 makes their growth independent of HER-2/neu expression. | T. Pannellini; M. Spadaro; E. Di Carlo; E. Ambrosino; M. Iezzi; A. Amici; P.-L. Lollini; G. Forni...; F. Cavallo; P. Musiani | 2006-01-01 | JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| Genetic algorithm against cancer. | F. Pappalardo; E. Mastriani; P.-L. Lollini; S. Motta | 2006-01-01 | - | Springer Verlag | 2.01 Capitolo / saggio in libro | - |
| Analysis of vaccine’s schedules using models. Nota bene: e' un lavoro del 2007, come attestato dai dati stampati nel lavoro stesso (Received 5 February 2007; accepted 11 February 2007; Available online 17 April 2007), ma il fascicolo della rivista, per qualche motivo di carattere editoriale, e' datato December 2006. | F. Pappalardo; S. Motta; P.L. Lollini; E. Mastriani | 2006-01-01 | CELLULAR IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role. | A. Palladini; A. Astolfi; S. Croci; C. De Giovanni; G. Nicoletti; A. Rosolen; F. Sartori; P.-L. L...ollini; L. Landuzzi; P. Nanni | 2006-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Terapia molecolare dei sarcomi | P.L. Lollini | 2006-01-01 | - | - | 8.04 Coordinamento di progetti di ricerca | - |
| Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma | K. Scotlandi; S. Perdichizzi; G. Bernard; G. Nicoletti; P. Nanni; P.-L. Lollini; A. Curti; M. C. ...Manara; S. Benini; A. Bernard; P. Picci | 2006-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Vaccines for tumour prevention | Lollini P.L.; Cavallo F.; Nanni P.; Forni G. | 2006-01-01 | NATURE REVIEWS CANCER | - | 1.01 Articolo in rivista | - |
| Cancer biology, what we know and what we don't know. | P. Nanni; C. De Giovanni; P.-L. Lollini | 2006-01-01 | - | Bononia University Press | 2.01 Capitolo / saggio in libro | - |
| Modeling tumor immunology. | P.-L. Lollini; S. Motta; F. Pappalardo. | 2006-01-01 | MATHEMATICAL MODELS AND METHODS IN APPLIED SCIENCES | - | 1.01 Articolo in rivista | - |
| CD99 Acts as an Oncosuppressor in Osteosarcoma. | Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.;... Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K. | 2006-01-01 | MOLECULAR BIOLOGY OF THE CELL | - | 1.01 Articolo in rivista | - |
| Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator. | P.-L. Lollini; S. Motta; F. Pappalardo | 2006-01-01 | BMC BIOINFORMATICS | - | 1.01 Articolo in rivista | 0035895.pdf |
| Model deconstruction of an immunoprevention vaccine | F. Pappalardo; P.-L. Lollini; S. Motta; E. Mastriani. | 2006-01-01 | - | Springer | 4.01 Contributo in Atti di convegno | - |
| Development of a K-edge micro CT for the study of tumor angiogenesis in small animals | G. Baldazzi; D. Bollini; M. Gambaccini; R. Golfieri; P. L. Lollini; A. Margotti; S. Masetti; G. N...icoletti; G. Pancaldi; L. Roma; P.L. Rossi; M. Zuffa | 2006-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile